Biopolymers for Biomedical and Biotechnological Applications. Группа авторов
Чтение книги онлайн.

Читать онлайн книгу Biopolymers for Biomedical and Biotechnological Applications - Группа авторов страница 24

Название: Biopolymers for Biomedical and Biotechnological Applications

Автор: Группа авторов

Издательство: John Wiley & Sons Limited

Жанр: Химия

Серия:

isbn: 9783527818303

isbn:

СКАЧАТЬ and chitosan can be used as drug/vitamin carriers and excipients in films, hydrogels, or powders for drug delivery systems or ophthalmologic formulations [228,234]. For example, chitosan hydrogels were already used as support for the controlled release of betahistine (a histidine analog) [215] (Table 2.4). Chitosan can also be used in contact lenses for eyes due to its optical clarity, mechanical stability, and wettability [235].

      Chitin‐based materials are promising materials for tissue engineering of nerves, blood vessels, or scaffolds for regenerative medicine. These structures have high porosity and structural integrity that promote cell adhesion and encourage cell function as important features for regenerative materials [228,235]. These polysaccharides also contribute to the activation of immune system, which was already demonstrated in some in vitro and in vivo trials [249].

      Chitinous polysaccharides are also commonly used as wound healing fibers [229] (Table 2.4). Some chitin and chitosan products are already commercially available, for example, in form of sponges, nonwoven dressings for burns or skin abrasions, and several other injuries, as well as gels for internal wounds [228].

      2.7.3.2 Pharmaceutical Applications

      Similar to biomedical applications, chitinous polysaccharides are also interesting materials for the pharmaceutical industry, due to its antimicrobial, antitumor, antioxidant, anticholesterol and hemostatic effect, and wound healing [250]. Chitin extracted from R. oryzae was shown to have anti‐hepatotoxic effect, preventing the liver damage against paracetamol and contributes to the increasing of body's defense system [240]. A. niger CGC was shown to prevent the early development of atherosclerosis in in vivo studies [251]. In pharma applications, these biomaterials can be used as carriers of encapsulated drugs for drug delivery devices, vaccine adjuvants, or an excipient powder that can be used as binder, disintegrator, and/or a lubricant agent [234,235,252].

      2.7.3.3 Food Applications

      Chitinous polysaccharides are also used as dietary fibers in some food products, since they have the capacity of lowering the cholesterol levels by blocking the absorption of fat and cholesterols in organism and are a glucose‐lowering agent [234,250]. In this way, these fibers facilitate the weight and fat loss and have a control over nutrition [234]. For example, there are several reports showing that the addition of fungal CGC as a fiber in food formulations has a beneficial effect in the development of obesity and diabetes and in the treatment of heart diseases [242,243,245] (Table 2.4).

      Chitosan is also known to be beneficial for food preservation as a coating for food packaging, acting as an inhibitor of microbial growth [207].

      2.7.3.4 Other Applications

      In textile industry, chitin fibers are also used despite their low tensile strength. In this way, chitin is usually used as a coating material for cellulosic, nylons, cotton, and wool fibers. The use of these modified fibers includes the production of wound dressings, medical textiles, sanitary absorbents, underwear, and waterproof textiles [207].

      Chitinous polysaccharides are antimicrobial and have metal ion absorption capacity, features that make these biomaterials also valuable to agricultural products. These polysaccharides are considered valuable alternatives to synthetic chemical agents (bactericides), due to their antibacterial activity. There are several reports showing the role of chitinous polysaccharides in some fruit and vegetable resistance against fungal infections [207,217,224] (Table 2.4). Moreover, it was also reported that chitin can retain nutrients in the soil [234]. Another application of chitinous polysaccharides in agriculture is as a metal and mineral absorbent for the clarification of wines [253].

      The metal absorption capacity of chitinous polysaccharides also enables their use in wastewater treatment and bioremediation. For example, chitosan and CGC have the ability to remove copper, nickel, zinc, or cobalt ions from wastewater [241,254].

      Microbial polysaccharides are characterized by a range of valuable properties that render them suitable for broad areas of applications, including high‐value market niches like cosmetics, pharmaceuticals, and biomedicine. Such biopolymers often possess novel or improved properties compared with synthetic polysaccharides, as well as those obtained from other natural sources (e.g. plants, algae, and animals). Besides their already established uses mostly as rheology modifiers, texturing agents, and bioemulsifiers, many microbial polysaccharides are currently arising as relevant bioactive materials displaying antioxidant, antitumor, immune enhancer, antiaging, and cholesterol lowering, which render them potentially suitable for the development of novel pharmaceuticals, nutraceuticals, and cosmetic products. Moreover, there is intense research related to their use in biopolymeric structures (e.g. hydrogels, bionanocomposites, etc.) possessing advantageous properties compared with other commercial materials. There are a growing number of reports on the isolation of new microbial sources that synthesize polysaccharides with distinctive properties, which may translate into the development of novel biomaterials or active drugs. Therefore, microorganisms represent a still underexplored source of products that, given the current research interest in their study, will surely translate into high‐value novel products, particularly for the pharmaceutical and nutraceutical industries.

      1 1 Moscovici, M. (2015). Present and future medical applications of microbial exopolysaccharides. Frontiers in Microbiology 6: 1012.

      2 2 Rehm, B.H.A. (2009). Microbial Production of Biopolymers and Polymer Precursors: Applications and Perspectives. Caister Academic Press.

      3 3 Rühmann, B., Schmid, J., and Sieber, V. (2015). Methods to identify the unexplored diversity of microbial exopolysaccharides. Frontiers in Microbiology 6: 565.

      4 4 Freitas, F., Alves, V.D., and Reis, M.A.M. (2011). Advances in bacterial exopolysaccharides: from production to biotechnological applications. Trends in Biotechnology 29 (8): 388–398.

      5 5 Cress, B.F., Englaender, J.A., He, W. et al. (2014). Masquerading microbial pathogens: capsular polysaccharides mimic host‐tissue molecules. FEMS Microbiology Reviews 38: 660–697.

      6 6 Freitas, F., Torres, C.A.V., and Reis, M.A.M. (2017). Engineering aspects of microbial exopolysaccharide production. Bioresource Technology 245: 1674–1683.

      7 7 СКАЧАТЬ